The co-occurrence of mutations of all three genes has previously been suggested to define a specific subtype of AML with unique epigenetic features10 and frequent mutations of NPM1 and FLT3 in DNMT3A-mutant patients have also been observed in other AML studies9,25,50. This evidence concerns the gene FLT3 and acute myeloid leukemia.